Reporting centers and number of transplants performed
|
||||
COUNTRY | CITY | HOSPITAL | No of TX | No of TX/Country |
Portugal | Lisbon | Hospital Curry Cabral | 273 | 591 |
Porto | Hospital Sto Antonio | 236 | ||
Coimbra | Coimbra University Hospital | 82 | ||
France | Villejuif | Hospital Paul Brousse/Kremlin Bicêtre | 181 | 195 |
Lyon | Hospital Edouard Herriot | 5 | ||
Strasbourg | Hôpital Hautepierre | 4 | ||
Clichy | Hospital Beaujon | 3 | ||
Marseille | Hospital de la Conception | 2 | ||
Sweden | Stockholm | Karolinska University Hospital Huddinge | 66 | 83 |
Gothenburg | Sahlgrenska University Hospital | 16 | ||
Uppsala | Uppsala University Hospital | 1 | ||
USA | Rochester | Mayo Clinic | 38 | 82 |
Burlington | Lahey Clinic Medical Center | 12 | ||
San Francisco | UCSF Medical Center | 10 | ||
Miami | University of Miami | 6 | ||
Philadelphia | The Penn Transplant Center | 5 | ||
Phoenix | Mayo Clinic | 4 | ||
Baltimore | University of Maryland | 3 | ||
Chapel Hill | UNC Comprehensive Transplant Center | 2 | ||
Pittsburgh | Thomas E Starzl Transplantation Institute | 1 | ||
Cleveland | University Hospitals of Cleveland | 1 | ||
Spain | Barcelona | Hospital de Bellvitge | 43 |
68 |
Seville | University Hospital Virgen del Rocio | 15 | ||
Vizcaya | Hospital de Cruces Barakaldo | 6 | ||
Barcelona | Hospital Vall D'Hebron | 2 | ||
Pamplona | Clínica Universitaria | 2 | ||
Germany | Mainz | Der Johannes Gutenberg Universität | 24 | 59 |
Hannover | Medizinische Hochschule | 15 | ||
Heidelberg | Chirurgische Universitätsklinik | 10 | ||
Tübingen | Klinikum der Universität | 10 | ||
Münster | Universitätsklinikum | 1 | ||
Brazil | São Paulo | Hospital Albert Einstein | 36 | 57 |
Santo Amaro | Oswaldo Cruz University Hospital | 12 | ||
Rio de Janeiro | Federal University of Rio de Janeiro | 9 | ||
Japan | Kumamoto | Kumamoto University Hospital | 25 | 54 |
Kyoto | Kyoto University | 10 | ||
Matsumoto | Shinshu University Hospital | 7 | ||
Tokyo | National Center for Child Health and Development | 4 | ||
Tokyo | Tokyo University Hospital | 3 | ||
Niigata | Niigata University Hospital | 2 | ||
Sapporo | Sapporo University Hospital | 2 | ||
Fukuoka | Kyushu University | 1 | ||
Belgium | Brussels | UCL St Luc | 14 | 21 |
Liège | CHU Sart Tilman | 4 | ||
Gent | University Hospital | 3 | ||
China | Beijing | Beijing Friendship Hospital | 17 | 18 |
Hong Kong | Queen Mary Hospital | 1 | ||
Switzerland | Genève | Hospital Cantonal | 10 | 15 |
Bern | Inselspital | 5 | ||
UK | London | King´s College | 11 | 12 |
Birmingham | Queen Elizabeth Hospital | 1 | ||
Canada | London | London Health Science Center | 4 | 9 |
Toronto | Toronto General Hospital | 3 | ||
Montreal | Hospital Saint-Luc | 2 | ||
Netherlands | Groningen | University Hospital | 5 | 7 |
Rotterdam | University Medical Center | 2 | ||
Italy | Torino | Molinette Hospital | 5 | 7 |
Milan | National Cancer Institute | 1 | ||
Milan | Hospital Maggiore | 1 | ||
India | New Delhi | Sir Ganga Ram Hospital | 1 | 3 |
Haryana | Medanta - The Medicity | 1 | ||
Coimbatore | Kovai Medical Center and Hospital | 1 | ||
Australia | Sydney | Royal Prince Alfred Hospital | 2 | 2 |
Taiwan | Taipei | Taipei Veterans General Hospital | 2 | 2 |
Argentina | Buenos Aires | Hospital C Argerich | 1 | 1 |
Romania | Bucharest | Fundeni Clinical Institute | 1 | 1 |
Norway | Oslo | Rikshospitalet | 1 | 1 |
Recipient
characteristics:
Sex
distribution: Male 74% / Female 26%
Age:
Mean 55.5±10.6 yrs, median 57.1 yrs, range 0.3 – 73.9
Indications for domino liver transplantation | No of cases |
Primary hepatic malignancy |
540 |
Metastatic hepatic malignancy | 30 |
Alcoholic cirrhosis | 239 |
Cirrhosis secondary to hepatitis B and C | 216 |
Retransplantation | 67 |
Other miscellaneous diagnoses | 184 |
Diagnosis not specified | 13 |
Donor
diseases:
FAP, Fibrinogen a-chain amyloidosis, Hyperoxalosis
Main
causes of death (only recipients of FAP livers):
Tumor
recurrence 21%
Septicemia
15%
Cardiac
related deaths 7%
Peroperative
deaths 4%
Domino
liver transplantation demonstrate excellent results and is a valuable donor
liver resource to selected patients. However, the risk of disease transmission in a proportion of patients is real and needs to be considered.